Pembrolizumab plus chemotherapy-induced pneumonitis in chemo-naïve patients with non-squamous non-small cell lung cancer: A multicentre, retrospective cohort study
-
Published:2021-06
Issue:
Volume:150
Page:63-72
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Fujimoto DaichiORCID, Miura SatoruORCID, Yoshimura Kenichi, Wakuda KazushigeORCID, Oya Yuko, Yokoyama ToshihideORCID, Yokoi TakashiORCID, Asao TetsuhikoORCID, Tamiya Motohiro, Nakamura Atsushi, Yoshioka Hiroshige, Haratani Koji, Teraoka ShunsukeORCID, Tokito Takaaki, Murakami Shuji, Tamiya Akihiro, Itoh Shoichi, Yokouchi Hiroshi, Watanabe SatoshiORCID, Yamaguchi Ou, Tomii Keisuke, Yamamoto Nobuyuki
Subject
Cancer Research,Oncology
Reference28 articles.
1. Cancer statistics, 2020;Siegel;CA Cancer J Clin,2020 2. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship;Molina;Mayo Clin Proc,2008 3. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer;Reck;N Engl J Med,2016 4. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N Engl J Med,2015 5. Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial;Rittmeyer;Lancet,2017
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|